<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">35821212</PMID><DateCompleted><Year>2022</Year><Month>07</Month><Day>14</Day></DateCompleted><DateRevised><Year>2023</Year><Month>01</Month><Day>19</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2041-4889</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>7</Issue><PubDate><Year>2022</Year><Month>Jul</Month><Day>13</Day></PubDate></JournalIssue><Title>Cell death &amp; disease</Title><ISOAbbreviation>Cell Death Dis</ISOAbbreviation></Journal><ArticleTitle>Mid1 is associated with androgen-dependent axonal vulnerability of motor neurons in spinal and bulbar muscular atrophy.</ArticleTitle><Pagination><StartPage>601</StartPage><MedlinePgn>601</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">601</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41419-022-05001-6</ELocationID><Abstract><AbstractText>Spinal and bulbar muscular atrophy (SBMA) is an adult-onset hereditary neurodegenerative disease caused by the expansions of CAG repeats in the androgen receptor (AR) gene. Androgen-dependent nuclear accumulation of pathogenic AR protein causes degeneration of lower motor neurons, leading to progressive muscle weakness and atrophy. While the successful induction of SBMA-like pathology has been achieved in mouse models, mechanisms underlying motor neuron vulnerability remain unclear. In the present study, we performed a transcriptome-based screening for genes expressed exclusively in motor neurons and dysregulated in the spinal cord of SBMA mice. We found upregulation of Mid1 encoding a microtubule-associated RNA binding protein which facilitates the translation of CAG-expanded mRNAs. Based on the finding that lower motor neurons begin expressing Mid1 during embryonic stages, we developed an organotypic slice culture system of the spinal cord obtained from SBMA mouse fetuses to study the pathogenic role of Mid1 in SBMA motor neurons. Impairment of axonal regeneration arose in the spinal cord culture in SBMA mice in an androgen-dependent manner, but not in mice with non-CAG-expanded AR, and was either exacerbated or ameliorated by Mid1 overexpression or knockdown, respectively. Hence, an early Mid1 expression confers vulnerability to motor neurons, at least by inducing axonogenesis defects, in SBMA.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ogura</LastName><ForeName>Yosuke</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0002-5251-9176</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Nagoya University Graduate School of Medicine, Nagoya, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sahashi</LastName><ForeName>Kentaro</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0003-3256-9659</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Nagoya University Graduate School of Medicine, Nagoya, Japan. sahashik@med.nagoya-u.ac.jp.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hirunagi</LastName><ForeName>Tomoki</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Neurology, Nagoya University Graduate School of Medicine, Nagoya, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Iida</LastName><ForeName>Madoka</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neurology, Nagoya University Graduate School of Medicine, Nagoya, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miyata</LastName><ForeName>Takaki</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Anatomy and Cell Biology, Nagoya University Graduate School of Medicine, Nagoya, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Katsuno</LastName><ForeName>Masahisa</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-9453-9311</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Nagoya University Graduate School of Medicine, Nagoya, Japan. ka2no@med.nagoya-u.ac.jp.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Research Education, Nagoya University Graduate School of Medicine, Nagoya, Japan. ka2no@med.nagoya-u.ac.jp.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>07</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Cell Death Dis</MedlineTA><NlmUniqueID>101524092</NlmUniqueID></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000728">Androgens</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.3.2.27</RegistryNumber><NameOfSubstance UI="C109037">Mid1 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.3.2.27</RegistryNumber><NameOfSubstance UI="D044767">Ubiquitin-Protein Ligases</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000728" MajorTopicYN="Y">Androgens</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055534" MajorTopicYN="Y">Bulbo-Spinal Atrophy, X-Linked</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009133" MajorTopicYN="N">Muscular Atrophy</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019636" MajorTopicYN="Y">Neurodegenerative Diseases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D044767" MajorTopicYN="Y">Ubiquitin-Protein Ligases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>1</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>6</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>5</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>7</Month><Day>12</Day><Hour>23</Hour><Minute>59</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>7</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>7</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35821212</ArticleId><ArticleId IdType="pmc">PMC9276699</ArticleId><ArticleId IdType="doi">10.1038/s41419-022-05001-6</ArticleId><ArticleId IdType="pii">10.1038/s41419-022-05001-6</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Hashizume A, Fischbeck KH, Pennuto M, Fratta P, Katsuno M. Disease mechanism, biomarker and therapeutics for spinal and bulbar muscular atrophy (SBMA) J Neurol Neurosurg Psychiatry. 2020;91:1085&#x2013;91.</Citation><ArticleIdList><ArticleId IdType="pubmed">32934110</ArticleId></ArticleIdList></Reference><Reference><Citation>La Spada AR, Wilson EM, Lubahn DB, Harding AE, Fischbeck KH. Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature. 1991;352:77&#x2013;79.</Citation><ArticleIdList><ArticleId IdType="pubmed">2062380</ArticleId></ArticleIdList></Reference><Reference><Citation>Katsuno M, Adachi H, Kume A, Li M, Nakagomi Y, Niwa H, et al. Testosterone reduction prevents phenotypic expression in a transgenic mouse model of spinal and bulbar muscular atrophy. Neuron. 2002;35:843&#x2013;54.</Citation><ArticleIdList><ArticleId IdType="pubmed">12372280</ArticleId></ArticleIdList></Reference><Reference><Citation>Minamiyama M, Katsuno M, Adachi H, Doi H, Kondo N, Iida M, et al. Naratriptan mitigates CGRP1-associated motor neuron degeneration caused by an expanded polyglutamine repeat tract. Nat Med. 2012;18:1531&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">23023499</ArticleId></ArticleIdList></Reference><Reference><Citation>Katsuno M, Adachi H, Minamiyama M, Waza M, Doi H, Kondo N, et al. Disrupted transforming growth factor-beta signaling in spinal and bulbar muscular atrophy. J Neurosci. 2010;30:5702&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6632356</ArticleId><ArticleId IdType="pubmed">20410122</ArticleId></ArticleIdList></Reference><Reference><Citation>Kemp MQ, Poort JL, Baqri RM, Lieberman AP, Breedlove SM, Miller KE, et al. Impaired motoneuronal retrograde transport in two models of SBMA implicates two sites of androgen action. Hum Mol Genet. 2011;20:4475&#x2013;90.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3196895</ArticleId><ArticleId IdType="pubmed">21873607</ArticleId></ArticleIdList></Reference><Reference><Citation>Poort JE, Rheuben MB, Breedlove SM, Jordan CL. Neuromuscular junctions are pathological but not denervated in two mouse models of spinal bulbar muscular atrophy. Hum Mol Genet. 2016;25:3768&#x2013;83.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5216617</ArticleId><ArticleId IdType="pubmed">27493028</ArticleId></ArticleIdList></Reference><Reference><Citation>Young JE, Garden GA, Martinez RA, Tanaka F, Sandoval CM, Smith AC, et al. Polyglutamine-expanded androgen receptor truncation fragments activate a Bax-dependent apoptotic cascade mediated by DP5/Hrk. J Neurosci. 2009;29:1987&#x2013;97.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2746676</ArticleId><ArticleId IdType="pubmed">19228953</ArticleId></ArticleIdList></Reference><Reference><Citation>Katsuno M, Adachi H, Minamiyama M, Waza M, Tokui K, Banno H, et al. Reversible disruption of dynactin 1-mediated retrograde axonal transport in polyglutamine-induced motor neuron degeneration. J Neurosci. 2006;26:12106&#x2013;17.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6675422</ArticleId><ArticleId IdType="pubmed">17122035</ArticleId></ArticleIdList></Reference><Reference><Citation>Iida M, Sahashi K, Kondo N, Nakatsuji H, Tohnai G, Tsutsumi Y, et al. Src inhibition attenuates polyglutamine-mediated neuromuscular degeneration in spinal and bulbar muscular atrophy. Nat Commun. 2019;10:4262.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6753158</ArticleId><ArticleId IdType="pubmed">31537808</ArticleId></ArticleIdList></Reference><Reference><Citation>Szebenyi G, Morfini GA, Babcock A, Gould M, Selkoe K, Stenoien DL, et al. Neuropathogenic forms of huntingtin and androgen receptor inhibit fast axonal transport. Neuron. 2003;40:41&#x2013;52.</Citation><ArticleIdList><ArticleId IdType="pubmed">14527432</ArticleId></ArticleIdList></Reference><Reference><Citation>Morfini G, Pigino G, Szebenyi G, You Y, Pollema S, Brady ST. JNK mediates pathogenic effects of polyglutamine-expanded androgen receptor on fast axonal transport. Nat Neurosci. 2006;9:907&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pubmed">16751763</ArticleId></ArticleIdList></Reference><Reference><Citation>Fargo KN, Galbiati M, Foecking EM, Poletti A, Jones KJ. Androgen regulation of axon growth and neurite extension in motoneurons. Horm Behav. 2008;53:716&#x2013;28.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2408920</ArticleId><ArticleId IdType="pubmed">18387610</ArticleId></ArticleIdList></Reference><Reference><Citation>Ottem EN, Beck LA, Jordan CL, Breedlove SM. Androgen-dependent regulation of brain-derived neurotrophic factor and tyrosine kinase B in the sexually dimorphic spinal nucleus of the bulbocavernosus. Endocrinology. 2007;148:3655&#x2013;65.</Citation><ArticleIdList><ArticleId IdType="pubmed">17463054</ArticleId></ArticleIdList></Reference><Reference><Citation>Marron TU, Guerini V, Rusmini P, Sau D, Brevini TAL, Martini L, et al. Androgen-induced neurite outgrowth is mediated by neuritin in motor neurones. J Neurochem. 2005;92:10&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pubmed">15606892</ArticleId></ArticleIdList></Reference><Reference><Citation>Kapur M, Monaghan CE, Ackerman SL. Regulation of mRNA translation in neurons&#x2014;a matter life death neuron. Neuron. 2017;96:616&#x2013;37.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5693308</ArticleId><ArticleId IdType="pubmed">29096076</ArticleId></ArticleIdList></Reference><Reference><Citation>Montague K, Malik B, Gray AL, La Spada AR, Hanna MG, Szabadkai G, et al. Endoplasmic reticulum stress in spinal and bulbar muscular atrophy: a potential target for therapy. Brain. 2014;137:1894&#x2013;906.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4065020</ArticleId><ArticleId IdType="pubmed">24898351</ArticleId></ArticleIdList></Reference><Reference><Citation>Leitman J, Barak B, Benyair R, Shenkman M, Ashery U, Hartl FU, et al. ER stress-induced eIF2-alpha phosphorylation underlies sensitivity of striatal neurons to pathogenic huntingtin. PLoS One. 2014;9:e90803.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3940916</ArticleId><ArticleId IdType="pubmed">24594939</ArticleId></ArticleIdList></Reference><Reference><Citation>Aranda-Orgill&#xe9;s B, Rutschow D, Zeller R, Karagiannidis AI, K&#xf6;hler A, Chen C, et al. Protein phosphatase 2A (PP2A)-specific ubiquitin ligase MID1 is a sequence-dependent regulator of translation efficiency controlling 3-phosphoinositide-dependent protein kinase-1 (PDPK-1) J Biol Chem. 2011;286:39945&#x2013;57.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3220588</ArticleId><ArticleId IdType="pubmed">21930711</ArticleId></ArticleIdList></Reference><Reference><Citation>Krauss S, Griesche N, Jastrzebska E, Chen C, Rutschow D, Achm&#xfc;ller C, et al. Translation of HTT mRNA with expanded CAG repeats is regulated by the MID1-PP2A protein complex. Nat Commun. 2013;4:1511.</Citation><ArticleIdList><ArticleId IdType="pubmed">23443539</ArticleId></ArticleIdList></Reference><Reference><Citation>Griesche N, Schilling J, Weber S, Rohm M, Pesch V, Matthes F, et al. Regulation of mRNA translation by MID1: a common mechanism of expanded CAG repeat RNAs. Front Cell Neurosci. 2016;10:226.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5054010</ArticleId><ArticleId IdType="pubmed">27774050</ArticleId></ArticleIdList></Reference><Reference><Citation>K&#xf6;hler A, Demir U, Kickstein E, Krauss S, Aigner J, Aranda-Orgill&#xe9;s B, et al. A hormone-dependent feedback-loop controls androgen receptor levels by limiting MID1, a novel translation enhancer and promoter of oncogenic signaling. Mol Cancer. 2014;13:146.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4074869</ArticleId><ArticleId IdType="pubmed">24913494</ArticleId></ArticleIdList></Reference><Reference><Citation>Waza M, Adachi H, Katsuno M, Minamiyama M, Sang C, Tanaka F, et al. 17-AAG, an Hsp90 inhibitor, ameliorates polyglutamine-mediated motor neuron degeneration. Nat Med. 2005;11:1088&#x2013;95.</Citation><ArticleIdList><ArticleId IdType="pubmed">16155577</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu T, Chen R, Cox TC, Moldrich RX, Kurniawan N, Tan G, et al. X-linked microtubule-associated protein, Mid1, regulates axon development. Proc Natl Acad Sci USA. 2013;110:19131&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3839708</ArticleId><ArticleId IdType="pubmed">24194544</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng H, Snoek R, Ghaidi F, Cox ME, Rennie PS. Short hairpin RNA knockdown of the androgen receptor attenuates ligand-independent activation and delays tumor progression. Cancer Res. 2006;66:10613&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pubmed">17079486</ArticleId></ArticleIdList></Reference><Reference><Citation>Ge SX, Son EW, Yao R. iDEP: an integrated web application for differential expression and pathway analysis of RNA-Seq data. BMC Bioinforma. 2018;19:534.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6299935</ArticleId><ArticleId IdType="pubmed">30567491</ArticleId></ArticleIdList></Reference><Reference><Citation>Blum JA, Klemm S, Shadrach JL, Guttenplan KA, Nakayama L, Kathiria A, et al. Single-cell transcriptomic analysis of the adult mouse spinal cord reveals molecular diversity of autonomic and skeletal motor neurons. Nat Neurosci. 2021;24:572&#x2013;83.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8016743</ArticleId><ArticleId IdType="pubmed">33589834</ArticleId></ArticleIdList></Reference><Reference><Citation>Miyata T, Kawaguchi A, Okano H, Ogawa M. Asymmetric inheritance of radial glial fibers by cortical. Neurons Neuron. 2001;31:727&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pubmed">11567613</ArticleId></ArticleIdList></Reference><Reference><Citation>Miyata T, Kawaguchi A, Saito K, Kawano M, Muto T, Ogawa M. Asymmetric production of surface-dividing and non-surface-dividing cortical progenitor cells. Development. 2004;131:3133&#x2013;45.</Citation><ArticleIdList><ArticleId IdType="pubmed">15175243</ArticleId></ArticleIdList></Reference><Reference><Citation>Miyata T, Ono Y, Okamoto M, Masaoka M, Sakakibara A, Kawaguchi A, et al. Migration, early axonogenesis, and Reelin-dependent layer-forming behavior of early/posterior-born Purkinje cells in the developing mouse lateral cerebellum. Neural Dev. 2010;5:23.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2942860</ArticleId><ArticleId IdType="pubmed">20809939</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim WF, Forouhan M, Roberts TC, Dabney J, Ellerington R, Speciale AA, et al. Gene therapy with AR isoform 2 rescues spinal and bulbar muscular atrophy phenotype by modulating AR transcriptional activity. Sci Adv. 2021;7:eabi6896..</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8378820</ArticleId><ArticleId IdType="pubmed">34417184</ArticleId></ArticleIdList></Reference><Reference><Citation>Cashman NR, Durham HD, Blusztajn JK, Oda K, Tabira T, Shaw IT, et al. Neuroblastoma x spinal cord (NSC) hybrid cell lines resemble developing motor neurons. Dev Dyn. 1992;194:209&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pubmed">1467557</ArticleId></ArticleIdList></Reference><Reference><Citation>Dal Zotto L, Quaderi NA, Elliott R, Lingerfelter PA, Carrel L, Valsecchi V, et al. The mouse Mid1 gene: implications for the pathogenesis of Opitz syndrome and the evolution of the mammalian pseudoautosomal region. Hum Mol Genet. 1998;7:489&#x2013;99.</Citation><ArticleIdList><ArticleId IdType="pubmed">9467009</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinson L, Aug&#xe9; J, Audollent S, Matt&#xe9;i G, Etchevers H, Gigarel N, et al. Embryonic expression of the human MID1 gene and its mutations in Opitz syndrome. J Med Genet. 2004;41:381&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1735763</ArticleId><ArticleId IdType="pubmed">15121778</ArticleId></ArticleIdList></Reference><Reference><Citation>Bucchia M, Merwin SJ, Re DB, Kariya S. Limitations and challenges in modeling diseases involving spinal motor neuron degeneration in vitro. Front Cell Neurosci. 2018;12:61.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5845677</ArticleId><ArticleId IdType="pubmed">29559895</ArticleId></ArticleIdList></Reference><Reference><Citation>Croft CL, Futch HS, Moore BD, Golde TE. Organotypic brain slice cultures to model neurodegenerative proteinopathies. Mol Neurodegener. 2019;14:45.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6889333</ArticleId><ArticleId IdType="pubmed">31791377</ArticleId></ArticleIdList></Reference><Reference><Citation>Torres-Esp&#xed;n A, Santos D, Gonz&#xe1;lez-P&#xe9;rez F, del Valle J, Navarro X. Neurite-J: an Image-J plug-in for axonal growth analysis in organotypic cultures. J Neurosci Methods. 2014;236:26&#x2013;39.</Citation><ArticleIdList><ArticleId IdType="pubmed">25124852</ArticleId></ArticleIdList></Reference><Reference><Citation>Avossa D, Grandolfo M, Mazzarol F, Zatta M, Ballerini L. Early signs of motoneuron vulnerability in a disease model system: characterization of transverse slice cultures of spinal cord isolated from embryonic ALS mice. Neuroscience. 2006;138:1179&#x2013;94.</Citation><ArticleIdList><ArticleId IdType="pubmed">16442737</ArticleId></ArticleIdList></Reference><Reference><Citation>Trockenbacher A, Suckow V, Foerster J, Winter J, Krauss S, Ropers HH, et al. MID1, mutated in Opitz syndrome, encodes an ubiquitin ligase that targets phosphatase 2A for degradation. Nat Genet. 2001;29:287&#x2013;94.</Citation><ArticleIdList><ArticleId IdType="pubmed">11685209</ArticleId></ArticleIdList></Reference><Reference><Citation>Malik B, Devine H, Patani R, La Spada AR, Hanna MG, Greensmith L. Gene expression analysis reveals early dysregulation of disease pathways and links Chmp7 to pathogenesis of spinal and bulbar muscular atrophy. Sci Rep. 2019;9:3539.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6401132</ArticleId><ArticleId IdType="pubmed">30837566</ArticleId></ArticleIdList></Reference><Reference><Citation>Clarkson J, Herbison AE. Hypothalamic control of the male neonatal testosterone surge. Philos Trans R Soc Lond B Biol Sci. 2016;371:20150115.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4785901</ArticleId><ArticleId IdType="pubmed">26833836</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu L-Q, Zheng H-Y, Peng C-X, Liu D, Li H-L, Wang Q, et al. Protein phosphatase 2A facilitates axonogenesis by dephosphorylating CRMP2. J Neurosci. 2010;30:3839&#x2013;48.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6632239</ArticleId><ArticleId IdType="pubmed">20220019</ArticleId></ArticleIdList></Reference><Reference><Citation>Aranda-Orgill&#xe9;s B, Aigner J, Kunath M, Lurz R, Schneider R, Schweiger S. Active transport of the ubiquitin ligase MID1 along the microtubules is regulated by protein phosphatase 2A. PLoS One. 2008;3:e3507.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2568803</ArticleId><ArticleId IdType="pubmed">18949047</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>